Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04065022
Other study ID # S57869-1
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 20, 2017
Est. completion date January 16, 2018

Study information

Verified date August 2019
Source KU Leuven
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Transcranial alternating current stimulation (tACS) is a noninvasive neuromodulation method that works by passing alternating electric current between electrodes where at least one of them is attached to the head. This has been shown to have effects on the motor system, cognition and behavior. The exact mechanism by which tACS causes such effects is not fully understood. Some studies suggests a contribution from the stimulated peripheral nerves present in the scalp rather than direct brain effects. To test this hypothesis two arms will be done. First, 12 subjects (arm 1) will be stimulated using focused 4x1 montage with gel-filled cup-electrodes over the motor cortex and the effects will be compared between anesthetized and non-anesthetized scalp. The effects of anesthetizing the scalp will be tested on three different stimulation amplitudes off (0 mA), low (0.5 mA) and high (2.5 mA). Then, 10 subjects (arm 2) will be stimulated over the contralateral arm to exclude any direct brain stimulation effects and to test if peripheral nerve stimulation can entrain the tremor. Three outcome measurements will be measured during the experiments which are: tremor entrainment, sensation intensity and sensation threshold.


Recruitment information / eligibility

Status Completed
Enrollment 22
Est. completion date January 16, 2018
Est. primary completion date January 16, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Above 18

- Signed informed consents

Exclusion Criteria:

- Pregnancy

- History of Epilepsy

- Family history of Epilepsy

Study Design


Related Conditions & MeSH terms


Intervention

Device:
tACS at tremor frequency
tACS applied between the stimulation electrodes at tremor frequency

Locations

Country Name City State
Belgium KU Leuven Leuven

Sponsors (1)

Lead Sponsor Collaborator
KU Leuven

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in tremor-stimulation phase entrainment- Session 1 phase locking value was calculated between the tremor signal measured using accelerometer and the stimulation signal During session one of 12 minutes length (6 minutes with stimulation ON and 6 minutes with stimulation OFF)
Primary Change in tremor-stimulation phase entrainment- Session 2 phase locking value was calculated between the tremor signal measured using accelerometer and the stimulation signal During session two of 12 minutes length (6 minutes with stimulation ON and 6 minutes with stimulation OFF)
Primary Change in tremor-stimulation phase entrainment- Session 3 phase locking value was calculated between the tremor signal measured using accelerometer and the stimulation signal During session three of 12 minutes length (6 minutes with stimulation ON and 6 minutes with stimulation OFF)
Secondary Sensation rating The subject is asked to rate the sensation intensity during the stimulation at each stimulation amplitude using a visual analog scale from 0 to 10. Zero means the subject doesn't feel the stimulation and the number starts to increase as the sensation perception intensity increases to reach 10 if the subject feels it painful. Measured up to 5 minutes before the start of the stimulation sessions and lasts for 10 seconds of stimulation after which the subject gives the rating
Secondary Sensation threshold Stimulation amplitude at which the subject starts to feel the stimulation. Stimulation starts with 0 mA amplitude and then increased gradually until stimulation is perceived (or reaching maximum amplitude). Measured 3 minutes before the start of the stimulation sessions and lasts up to 2 minutes. Stimulation at each amplitude lasts for 10 seconds
See also
  Status Clinical Trial Phase
Completed NCT02334683 - Compare Two Guidance Techniques for Botulinum Toxin Injections for the Treatment of Limb Spasticity and Focal Dystonia N/A
Completed NCT02087046 - Deep Brain Stimulation (DBS) for the Suppression of Tremor N/A
Recruiting NCT02585583 - Deep Brain Frameless Radiosurgery for Drug Resistant Invalidating Tremor. Dose Escalation Pilot Study N/A
Completed NCT03337334 - Effects of High Amplitude and Focused tACS on Entraining Physiological Tremor N/A
Recruiting NCT04815382 - Effects of a Dynamic Upper Limb Orthosis in Patients With Parkinson's Disease N/A
Recruiting NCT03136341 - A Cross Over Pilot Study of Abobotulinum Toxin A (Dysport) as a Treatment for Task-dependent Upper Limb Tremor Phase 4